Intelligent Bio Solutions Inc (INBS)
2.27
-0.11
(-4.62%)
USD |
NASDAQ |
May 17, 16:00
2.22
-0.05
(-2.20%)
After-Hours: 20:00
Intelligent Bio Solutions Cash from Investing (Quarterly): 0.0026M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0026M |
| December 31, 2023 | -0.0567M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.1817M |
| March 31, 2023 | 0.1738M |
| December 31, 2022 | -0.2113M |
| September 30, 2022 | -0.4749M |
| June 30, 2022 | -0.703M |
| March 31, 2022 | -0.1772M |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -0.014M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| September 30, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.703M
Minimum
Jun 2022
0.1738M
Maximum
Mar 2023
-0.0966M
Average
--
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Ainos Inc | -0.1113M |
| OpGen Inc | -0.1017M |
| Zomedica Corp | 5.625M |
| LENSAR Inc | -1.226M |
| Eargo Inc (DELISTED) | -0.019M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.447M |
| Cash from Financing (Quarterly) | 10.77M |
| Free Cash Flow | -7.266M |
| Free Cash Flow Per Share (Quarterly) | -1.175 |
| Free Cash Flow to Equity (Quarterly) | -2.361M |
| Free Cash Flow Yield | -525.5% |